The US imposition of 25% tariffs is expected to have minimal impact on India, with over half of Indian exports remaining unaffected due to existing exemptions. Trade between the two nations reached $131.8 billion in fiscal year 2024-25. India remains firm on not offering duty concessions for agricultural, dairy, and GM products, citing religious sentiments.
India’s manufacturing sector surged to a 16-month high in July, reaching 59.1, fueled by robust order growth and output. Sales growth hit a near five-year peak, while production soared to a 15-month high. Despite this, business confidence dipped to a three-year low due to concerns about competition and inflation, with input and output prices remaining…
Bitcoin dipped below $115,200 due to fresh US tariffs and profit-taking, triggering significant liquidations across the crypto market. Altcoins mirrored Bitcoin’s decline, with XRP and Solana falling over 6%. Despite the downturn, analysts remain optimistic, citing institutional demand and positive signals in the BTC options market, suggesting potential consolidation and a Q4 breakout.
Gold price prediction today: Gold futures are facing pressure, struggling to recover, currently around ₹98,778. Technical indicators suggest a weak rebound, lacking bullish momentum. Experts advise a ‘Sell on Rise’ strategy near ₹99,000, with a stop-loss at ₹99,450, targeting ₹98,550 and ₹98,200. The trend remains vulnerable to declines until prices decisively break above the 21…
Bajaj Broking Research suggests that Nifty will consolidate between 24,500-25,000, while Bank Nifty is expected to rise towards 57,500-58,300. Amidst US-India trade tensions and RBI rate decisions, Axis Bank is recommended for purchase between Rs 1050-1070, targeting Rs 1175. Larsen and Toubro is also a buy, within Rs 3590-3640, with expectations to reach Rs 3963.
Donald Trump has issued a stern warning to major pharmaceutical companies, demanding they drastically reduce prescription drug prices in the US. In letters to firms like AbbVie, Trump insisted on implementing reforms to lower costs for American patients, who face some of the highest drug prices globally.
President Trump’s new tariffs, ranging from 10% to 41%, have sparked global reactions. Thailand and Cambodia hailed 19% tariff deals as wins after US intervention. Taiwan faces a 20% levy, hoping for reductions through negotiation. Canada strongly condemned the increased tariffs, labeling them as ‘tact-less turbulence,’ while defending its Prime Minister’s approach.
US President Donald Trump has implemented a revised trade tariff regime under his “America First” policy, effective August 7. It imposes a default 10% tariff on 68 nations and the EU, with higher rates for countries with trade deficits, starting at 15%. Syria faces the highest tariff at 41%.
